Download PDF
Dtsch Med Wochenschr 2008; 133(38): 1907-1910
DOI: 10.1055/s-0028-1085575
Aktuelle Diagnositk und Therapie
Hepatologie
© Georg Thieme Verlag KG Stuttgart · New York

Das hepatozelluläre Karzinom

Hepatocellular carcinoma – diagnosis and treatmentT. F. Greten1 , M. P. Manns1
  • 1Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover
Further Information

Publication History

eingereicht: 29.4.2008

akzeptiert: 10.7.2008

Publication Date:
10 September 2008 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

hepatozellulläres Karzinom - Leberzirrhose - Radiofrequenzablation - transarterielle Chemoembolisation

Key words

hepatocellular carcinoma - liver cirrhosis - radiofrequency ablation - transarterial chemoembolisation

Literatur

  • 1 Bruix J, Sherman M. Management of hepatocellular carcinoma.  Hepatology. 2005;  42 1208-1236
    Google Scholar
  • 2 Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.  Gastroenterology. 2004;  127 S35-50
    Google Scholar
  • 3 Ferlay J, Autier P, Boniol M. et al . Estimates of the cancer incidence and mortality in Europe in 2006.  Ann Oncol. 2007;  18 581-592
    Google Scholar
  • 4 Forner A, Vilana R, Ayuso C. et al . Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.  Hepatology. 2008;  47 97-104
    Google Scholar
  • 5 Garrean S, Hering J, Saied A, Helton W S, Espat N J. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature.  Am J Surg. 2008;  195 508-520
    Google Scholar
  • 6 Greten F R, Papendorf F, Bleck J S. et al . Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients.  Br J Cancer. 2005;  92 1862-1868
    Google Scholar
  • 7 Greten T F, Blum H E, Manns M P, Geissler M. Therapie des hepatozellulären Karzinoms.  Z Gastroenterol. 2006;  44 43-49
    Google Scholar
  • 8 Greten T F, Wedemeyer H, Manns M P. . Prävention Virus-assoziierter Karzinomentstehung: Am Beispiel des hepatozellulären Karzinoms.  Deutsches Ärzteblatt. 2006;  103 A-1817
    Google Scholar
  • 9 Greten T F. Molecular therapy for HCC?.  Z Gastroenterol. 2006;  44 205-206
    Google Scholar
  • 10 Llovet J M, Burroughs A, Bruix J. Hepatocellular carcinoma.  Lancet. 2003;  362 1907-1917
    Google Scholar
  • 11 Llovet L, Ricci S, Mazzaferro V. et al . Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): Results of a phase III randomized placebo-controlled trial (SHARP trial).  J Clin Oncol. 2007;  25 962s
    Google Scholar
  • 12 Mazzaferro V, Regalia E, Doci R. et al . Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.  N Engl J Med. 1996;  334 693-699
    Google Scholar
  • 13 Talwalkar J A, Gores G J. Diagnosis and staging of hepatocellular carcinoma.  Gastroenterology. 2004;  127 S126-132
    Google Scholar
  • 14 Varela M, Real M I, Burrel M. et al . Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.  J Hepatol. 2007;  46 474-481
    Google Scholar
  • 15 Williams R, White J, Croce M, Dilawari R. Surgical options in the treatment of hepatocellular carcinoma.  Am Surg. 2007;  73 658-662; discussion 662 – 653
    Google Scholar

Prof. Dr. Tim F. Greten

Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover

Carl Neuberg Str. 1

30625 Hannover

Email: greten.tim@mh-hannover.de

      >